Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Bone Disorders01:29

Bone Disorders

5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
What is the Skeletal System?01:02

What is the Skeletal System?

56.7K
Overview
56.7K
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

2.0K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.0K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

543
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
543
Essential Minerals for Bone Health01:31

Essential Minerals for Bone Health

5.9K
The minerals contained in all of the food we consume are essential for our organ systems. However, certain essential minerals, such as calcium, phosphorus, magnesium, manganese, and fluoride, largely affect bone health.
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
5.9K
The Functions of the Skeletal System01:22

The Functions of the Skeletal System

5.7K
The most apparent functions of the skeletal system are support, protection, and movement. However, bone tissue also performs several other critical metabolic functions. For one, the bone matrix acts as a reservoir for a number of minerals important to the functioning of the body, especially calcium and phosphorus. These minerals, present in the bone tissue, can be released back into the bloodstream when required. Calcium ions, for example, are essential for muscle contractions and controlling...
5.7K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Graft survival and rejection with repeated human leukocyte antigen (HLA) mismatch in kidney transplantation: a retrospective multicentre cohort study protocol.

BMC nephrology·2026
Same author

Use of romosozumab for osteoporosis in β-thalassemia major.

JBMR plus·2026
Same author

Vertebral fractures in a young woman: the impact of hypogonadism, glucocorticoids and chronic disease.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026
Same author

Asian ethnicity is associated with shorter anti-resorptive exposure prior to atypical femur fracture (AFF): a Transcontinental Atypical Femoral Fracture Consortium (TrAFFiC) cohort study.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026
Same author

Validating the FRAC-Stroke score: targeting those at highest risk of fracture.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026
Same author

Zoledronic acid improves bone mineral density at the lumbar spine and total hip in adults with chronic liver disease.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry·2026

Video Experimental Relacionado

Updated: Jan 14, 2026

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation
07:17

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation

Published on: April 14, 2016

87.3K

Anemia y enfermedad ósea

Karen Van1, Jasna Aleksova1, Phillip Wong2

  • 1Department of Endocrinology, Monash Health, Clayton, Vic, Australia; Department of Medicine, School of Clinical Sciences, Monash University, Clayton, Vic, Australia; Hudson Institute of Medical Research, Clayton, Vic, Australia.

Pathology
|January 12, 2026
PubMed
Resumen

La anemia y la enfermedad ósea están relacionadas, y el factor de crecimiento de fibroblastos-23 (FGF-23) afecta a ambas. Esta revisión destaca los riesgos óseos subestimados en pacientes con anemia y ofrece recomendaciones de monitorización.

Palabras clave:
anemiahuesoenfermedad renal crónicafactor de crecimiento de fibroblastos-23fracturahierroosteoporosistalasemia

Más Videos Relacionados

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.8K
Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

1.3K

Videos de Experimentos Relacionados

Last Updated: Jan 14, 2026

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation
07:17

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation

Published on: April 14, 2016

87.3K
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.8K
Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

1.3K

Sus antecedentes:

  • La anemia y la enfermedad ósea coexisten frecuentemente en afecciones crónicas como las hemoglobinopatías y la enfermedad renal crónica.
  • La salud ósea se ve comprometida por factores como la expansión de la médula, la sobrecarga de hierro, la disfunción endocrina y las alteraciones del metabolismo mineral, lo que aumenta el riesgo de fracturas.
  • Los avances terapéuticos actuales para la anemia pueden tener efectos subestimados en la salud ósea, detectándose a menudo la osteoporosis después de una fractura.

Conclusiones:

  • Existe una necesidad crítica de reconocer los riesgos esqueléticos asociados con la anemia y sus tratamientos.
  • La monitorización de los niveles de FGF-23 y fósforo es crucial, especialmente en pacientes que reciben terapias combinadas de antiresortivos y hierro parenteral.
  • Se proporcionan recomendaciones prácticas para tender un puente entre la comprensión mecanicista y la práctica clínica para mejorar el manejo de la salud ósea en pacientes anémicos.